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Dual infections by group A and group C rotaviruses have been reported, but no reassortants between group A and group
C rotaviruses have been described. The VP6 major inner capsid protein of group A and C rotaviruses shares common
antigens detected by monoclonal antibodies and also shares 40–43% amino acid identity. Coinfection of Spodoptera
frugiperda (Sf9) insect cells with different combinations of the recombinant baculoviruses encoding either group A {RF VP2
(A-VP2), IND VP6 (A-VP6), and VP7 (A-VP7[IND]), 2292B VP7 (A-VP7[2292B])} or C [Shintoku VP6 (C-VP6) and VP7 (C-VP7)]
bovine rotavirus proteins produced hybrid group A/C triple-layered VP2/6/7 virus-like particles (TLPs) composed of
A-VP2/C-VP6/C-VP7, A-VP2/C-VP6/A-VP7(IND), A-VP2/C-VP6/A-VP7(2292B), and A-VP2/A-VP6/C-VP7. To our knowledge, this
is the first report that the inner capsid VP6 of group A or group C rotavirus can support attachment of the heterologous,
antigenically distinct group A (G6, IND or G10, 2292B) or group C rotavirus outer capsid VP7 to produce hybrid TLPs in vitro.virus-liINTRODUCTION
Rotavirus is a nonenveloped double-stranded RNA
(dsRNA) virus belonging to the family Reoviridae. Rota-
virus is composed of three layers of structural capsid
proteins. The core comprises VP1, VP2, and VP3, and the
most abundant protein, VP6, makes up the inner capsid
layer. The outer capsid layer contains the major surface
glycoprotein VP7 and the hemagglutinin spike VP4, both
of which contain neutralization antigens (Estes and Co-
hen, 1989; Offit et al., 1986). Rotaviruses are divided into
seven serogroups (A–G) determined by the antigenic
properties of VP6, and each serogroup is further divided
into serotypes determined by VP4 (P type) and VP7 (G
type) (Estes and Cohen, 1989).
Most human and animal rotaviruses detected belong
to group A, which infects mainly young animals and
children causing diarrhea (Bohl et al., 1978; Fitzgerald et
al., 1988; Jones et al., 2000; Parwani et al., 1994; Saif et
al., 1994; Saif and Smith, 1985). Group B rotavirus has
been associated with annual outbreaks of diarrhea in
adults in China (Hung et al., 1984) as well as diarrhea in
animals (Saif and Jiang, 1994) and group C rotavirus has
been found in both sporadic cases and in outbreaks of
1 To whom correspondence and reprint requests should be ad-
dressed at Food Animal Health Research Program, Department of
Veterinary Preventive Medicine, Ohio Agricultural Research and Devel-1diarrhea in animals and humans (Caul et al., 1990; Fal-
cone et al., 1999; Jiang et al., 1995; Kim et al., 1999;
Maunula et al., 1992; Saif and Jiang, 1994; Tsunemitsu et
al., 1992). Even though group C rotaviruses have been
detected sporadically or in limited settings (Caul et al.,
1990; Jiang et al., 1995; Maunula et al., 1992), recent
antibody seroprevalence studies of group C rotavirus
have shown that 30 to 45% of the human sera tested
were positive in certain geographic locations (James et
al., 1997; Nilsson et al., 2000; Steele and James, 1999;
Talt et al., 1997). In animals, 50% of adult cattle and 93 to
97% of swine surveyed were seropositive for antibodies
to group C rotavirus in the United States and Japan (Saif
and Jiang, 1994; Tsunemitsu et al., 1992).
However, there are few studies of the interactions
among different rotavirus serogroups, including group A
and C rotaviruses, although seroprevalence studies
showed that group C rotaviruses might be more wide-
spread than indicated by detection from feces. In a diar-
rheic outbreak associated with group C rotaviruses in
feeder pigs, a trace amount of group A rotaviruses was
detected in the fecal samples from the diarrheic pigs, but
the role of group A rotaviruses in the diarrhea outbreak
was unclear (Kim et al., 1999). Chang et al. (1999) re-
ported that coinfection of calves with group A bovine
rotaviruses (BRV) enhanced the fecal shedding of a
group C BRV and the extent of histopathological lesions
in the small intestines. Dual infections with group C and
group A rotaviruses were also detected in diarrheic stool© 2002 Elsevier Science (USA)
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showed that different serogroups of rotavirus can simul-
taneously infect the same host; thus, there is a possibility
of generation of reassortants among rotavirus sero-
groups.
The deduced amino acid identities in VP6 between
group A and C rotaviruses are 40–43%, and among
groups A, B, and C are only 9–11%, whereas within a
group (A or C), VP6 shares 89–99% amino acid identity
(Bremont et al., 1990). To date, no reassortants between
group A and group C rotaviruses have been generated in
vitro or detected in vivo. Furthermore, Yolkin et al. (1988)
reported that no group A/B reassortants were detected
when infant rats were infected simultaneously with
group B IDIR and group A MMU rotavirus strains.
However, some investigators have reported antigenic
cross-reactivity between group A and group C VP6 using
monoclonal antibodies (Saif and Jiang, 1994; Tsumenitsu
et al., 1992). Furthermore, coexpression of the VP6 of
Cowden porcine group C rotavirus and the VP2 of RF
group A BRV in a baculovirus expression system resulted
in 2/6 DLPs, indicating conservation of the domains on
the VP6 responsible for binding to VP2 of a different
serogroup (A and C) (Tosser et al., 1992).
To investigate if VP6 could support the attachment of
heterologous rotavirus serogroup VP7 proteins to pro-
duce hybrid TLPs, we cloned the VP6 and VP7 genes of
group C BRV Shintoku strain, the VP6 gene of group A
BRV IND strain, and the VP7 genes of group A BRV IND
(G6 serotype) and 2292B (G10 serotype) strains to pro-
duce recombinant baculoviruses. To investigate if the
group B rotavirus VP6 and group A rotavirus VP2 could
form A-VP2/B-VP6 DLP, the VP6 gene of group B human
rotavirus (HRV) ADRV strain was also cloned. The Sf9
insect cells were coinfected with different combinations
of recombinant baculoviruses encoding group A, B, or C
rotavirus genes to produce hybrid virus-like particles
(VLPs). The DLPs and TLPs from group A or C rotavi-
ruses were characterized by immune electron micros-
copy (IEM), sodium dodecyl sulfate (SDS)-polyacryl-
amide gel electrophoresis (PAGE), and Western blotting
assays.
RESULTS
DLP and TLP formation and IEM characterization
Coexpression of A-VP2 with A-VP6 or C-VP6 produced
DLPs (Fig. 1). In IEM, the DLPs appeared as wheel-like
particles with short spikes with diameters around 50 to
55 nm. Coexpression of A-VP2 and group B ADRV VP6
did not produce DLPs (data not shown).
The 2/6/7 TLPs were produced for group A BRV (IND
TLPs) by coexpression of A-VP2/A-VP6/A-VP7(IND) (Fig.
2A). Hybrid 2/6/7 TLPs were generated for group A and C
BRV by coexpression of A-VP2/C-VP6/C-VP7 (Fig. 2B);
A-VP2/A-VP6/C-VP7; A-VP2/C-VP6/A-VP7(2292B) (Fig.
2C); and A-VP2/C-VP6/A-VP7(IND) proteins. By IEM, the
TLPs had a well-defined rim around the wheel-like
spikes and were about 70 to 75 nm in diameter (Fig. 2).
The group A BRV IND 2/6/7 TLPs were 75 to 90% TLPs
(with 10 to 25% DLPs). The group A/C hybrid TLPs com-
posed of A-VP2, C-VP6, and C-VP7, and those of A-VP2,
A-VP6, or C-VP6 and A-VP7 or C-VP7 contained approx-
imately 30 to 90% TLPs (with 10–70% DLPs). The homol-
ogous group A IND 2/6/7 TLPs were stable at 4°C for
more than 2 years, but the percentage of TLPs in the
group A/C hybrid 2/6/7 TLP preparations decreased
within a few months from 30 to 90% to only 5–20%
TLPs (to become mostly DLPs) as assessed by IEM.
Yield of the VLPs
The protein concentrations of the VLP preparations
were assayed using the Bio-Rad protein assay kit (Bio-
Rad Laboratories, Hercules, CA). The yields of the 2/6
DLPs composed of A-VP2/A-VP6 or A-VP2/C-VP6 were
approximately 900 and 150 g from 3.0  108 infected
Sf9 cells, respectively. The yields of the group A IND
2/6/7 TLPs or the group A/C hybrid 2/6/7 TLPs were
approximately 350 and 50–70 g from 3.0  108 of
infected Sf9 cells, respectively.
Protein composition of DLPs and TLPs
Purified DLPs and TLPs were analyzed by SDS-PAGE
and the gels were stained with Simply blue safestain to
confirm the presence of each structural protein in the
VLP preparations. In the 2/6 DLPs, only VP2 and VP6
were detected (Fig. 3A). Comparison of the different
proteins in the 2/6/7 TLPs analyzed by SDS-PAGE or
Western blotting assays showed that each of the genes
used to infect the insect cells was expressed and incor-
porated into each of the respective particle types.
The proteins in the VLP preparations and the native
BRVs were detected by a Western blotting assay with
polyclonal hyperimmune antisera raised against group A
Wa HRV or group C Shintoku BRV in guinea pigs (Figs. 3B
and C) (Fig. 4, Fig. 5). Interestingly, the group A RF VP2
FIG. 1. Immune electron micrographs of DLPs. The DLPs were
incubated with highly diluted guinea pig antiserum against either group
A HRV Wa strain (A) or group C BRV Shintoku strain (B) and stained with
phosphotunstic acid (pH 7.0). (A) Double-layered particles composed of
A-VP2 and A-VP6. (B) Hybrid DLPs composed of A-VP2 and C-VP6.
Bar  75 nm.
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and IND VP6 in 2/6 DLPs (Fig. 3B, Lane 1) and IND VP6
in hybrid 2/6/7 TLPs composed of A-VP2/A-VP6/C-VP7
(Fig. 4A, Lane 1) were also detected by the hyperimmune
antiserum against group C Shintoku rotavirus. Further-
more, the VP6 of native IND BRV was reactive with group
C rotavirus antiserum (Fig. 5A, Lane 2), indicating that the
VP6 of native IND BRV, as well as the recombinant IND
VP6, has cross-reactivity with antiserum against group C
Shintoku BRV. The VP6 of the group C Shintoku BRV was
detected by group C Shintoku antiserum, and the VP7 of
the Shintoku group C BRV was faintly reactive with the
group C antiserum (Fig. 5A, Lane 1). However, the group
C rotavirus VP6 in the hybrid 2/6 DLPs composed of
A-VP2/C-VP6 (Fig. 3C), hybrid 2/6/7 TLPs composed of
A-VP2/C-VP6/A-VP7(2292B) (Fig. 4B, Lane 1) and A-VP2/
C-VP6/A-VP7(IND), and native group C Shintoku BRV (Fig.
5B, Lane 2) was not detected by the hyperimmune anti-
serum against group A Wa HRV.
DISCUSSION
Rotavirus is a major cause of diarrhea in animals and
humans worldwide (Avendano et al., 1993; Estes, 1996;
Saif and Fernandez, 1996; Saif et al., 1994). The economic
impact of rotavirus infections in animal husbandry and
human society has led to extensive studies of rotavirus
and the development of rotavirus vaccines. Rotavirus is a
unique dsRNA virus possessing a genome with 11 seg-
ments and three capsid layers surrounding the genome
(Estes, 1996).
FIG. 2. Immune electron micrographs of rotavirus TLPs. The TLPs were incubated with highly diluted guinea pig antiserum against either group
A HRV Wa strain (A and B) or group C BRV Shintoku strain (C) and stained with phosphotunstic acid (pH 7.0). (A) Triple-layered particles composed
of A-VP2/A-VP6/A-VP7(IND). (B) Triple-layered particles composed of A-VP2/A-VP6/C-VP7. (C) Triple-layered particles composed of A-VP2/C-VP6/A-VP7
(2292B). Bar  75 nm.
FIG. 3. The DLPs composed of A-VP2/A-VP6 or A-VP2/C-VP6 were
separated on acrylamide gels and stained with Simply blue safestain or
transferred to nitrocellulose membranes for Western blotting assay. (A)
The individual rotavirus proteins in the DLPs were stained on acryl-
amide gels. The hybrid DLPs composed of A-VP2/C-VP6 were concen-
trated five times more than the DLPs of A-VP2/A-VP6 before loading
onto acrylamide gels. M, molecular weight markers (kilodaltons). Lane
1, the DLPs composed of A-VP2/A-VP6; Lane 2, the hybrid DLPs com-
posed of A-VP2/C-VP6. (B) Western blot of the DLPs composed of
A-VP2/A-VP6 using antiserum against group C BRV Shintoku strain
(Lane 1). C. Western blot of the DLPs composed of A-VP2/C-VP6 using
antiserum against the group A HRV Wa strain. F, VP2; }, VP6.
FIG. 4. The TLPs were separated on the acrylamide gels and trans-
ferred to nitrocellulose membranes for Western blotting assay. (A)
Western blot of the TLPs using antiserum against group C bovine
Shintoku rotavirus. Lane 1, the TLPs composed of A-VP2/A-VP6/C-VP7;
Lane 2, the TLPs composed of A-VP2/C-VP6/C-VP7. (B) Western blot of
the TLPs using antiserum against group A HRV Wa strain. Lane 1, the
TLPs composed of A-VP2/C-VP6/A-VP7(2292B); Lane 2, the TLPs com-
posed of A-VP2/A-VP6/A-VP7(IND). (C) Western blot of the TLPs com-
posed of A-VP2/A-VP6/C-VP7 using antisera against group A HRV Wa
and group C BRV shintoku strains. F, VP2; }, VP6; Š, VP7.
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Rotavirus infects and replicates in mature enterocytes
in the small intestines. At cell entry, the outer capsid
proteins, VP4 and VP7, are removed and genomic tran-
scription occurs within the double-layered particles. The
new viral single-stranded (ss) mRNAs are extruded into
the cytoplasm, and the replication of viral mRNAs occurs
in specialized regions of the cell cytoplasm, the viro-
plasm. The rotavirus RNA replication and encapsidation
into the DLPs composed of VP1, 2, 3 and VP6 occur
concurrently or RNA replication follows the encapsida-
tion of viral mRNA in rotavirus-infected cells (Patton et al.,
1997). The immature DLPs with VP4 bud across the
rough endoplasmic reticulum, transiently acquiring a
membrane (Offit, 1994), and their maturation is com-
pleted by the incorporation of the outer capsid protein,
VP7, in the endoplasmic reticulum where infectious rota-
virus particles accumulate until cell lysis (Estes and
Cohen, 1989).
Group A rotaviruses frequently undergo natural reas-
sortment in vivo or artificial reassortment in vitro in coin-
fected cells (Ramig and Ward, 1991; Ward et al., 1988,
1991). Multivalent attenuated vaccines have been devel-
oped for group A HRV by producing reassortants com-
posed of different rotavirus serotypes in cultured cells.
Furthermore, the genetic composition of the rotavirus
reassortants differed when generated in animals or in
cell cultures, demonstrating that host and cellular selec-
tion processes occur during rotavirus reassortment
(Gouvea and Brantly, 1995; Ramig and Ward, 1991, Ward
et al., 1991). However, reassortant formation among dif-
ferent rotavirus serogroups has not yet been described,
although coinfections by group A and C rotaviruses in
animals and humans have been reported (Chang et al.,
1999; Jiang et al., 1995; Kim et al., 1999). The difficulty in
detecting reassortants in vivo and in vitro led us to
conduct these studies using the recombinant rotavirus
proteins in a baculovirus expression system.
When the recombinant group A rotavirus proteins, VP2
and VP6, or VP2, VP4, VP6, and VP7 were coexpressed in
insect cells, they self-assembled and formed 2/6 DLPs or
2/4/6/7 TLPs, respectively (Avendano et al., 1993; Craw-
ford et al., 1994; Labbe et al., 1991). These 2/6 DLPs or
2/4/6/7 TLPs were similar to the native double-layered
and triple-layered rotavirus particles, respectively, in
morphology, antigenicity, and protein composition, ex-
cept that the VLPs lack the virus genome. Therefore, the
recombinant baculoviruses encoding the structural pro-
tein genes of rotavirus have been used for coinfection of
the insect cells to investigate the interaction of the ex-
pressed recombinant proteins. Tosser et al. (1992)
showed that coexpression of the VP6 of Cowden porcine
group C rotavirus and the VP2 of RF group A BRV in a
baculovirus expression system resulted in 2/6 DLPs,
indicating that the domains in the group C VP6 for bind-
ing to the VP2 of a different serogroup (group A) are
conserved. Our study confirmed this finding for a group C
BRV by coinfecting the insect cells with recombinant
baculoviruses encoding the VP2 gene of the group A RF
BRV and the VP6 gene of the group C Shintoku BRV to
produce 2/6 DLPs. However, coexpression of group A RF
VP2 and group B ADRV VP6 proteins did not result in
detectable 2/6 DLPs, indicating that the VP2-binding do-
mains of group B rotavirus VP6 are divergent from those
of group A rotaviruses (data not shown).
Monoclonal antibodies against the VP6 of Cowden
group C rotavirus react with human and bovine group A
rotaviruses, further confirming that the VP6 of group A
and C rotaviruses share common epitopes (Saif and
Jiang, 1994; Tsunemitsu et al., 1992). In this study, the
cross-reactivity of the VP6 and VP2 proteins of group A
rotavirus with polyclonal antiserum against group C ro-
tavirus was demonstrated with the hybrid VLPs as well
as with the native group A IND BRV. Because the VP6 is
the most abundant rotavirus protein, comprising approx-
imately 60% of the rotavirus mass, and the amino acid
identity of VP6 between group A and group C rotaviruses
is moderate, it is not surprising that there is cross-
reactivity between group A and group C rotaviruses.
Although the group C Shintoku rotavirus was not reactive
with polyclonal antiserum against group A Wa HRV in our
study, it is possible that the cross-reactivity is weak and
beyond our detection limit due to the lower concentration
of group C Shintoku rotavirus (data not shown). Although
some researchers reported that there was no serological
cross-reactivity between group A and C rotaviruses by
FIG. 5. The Western blot of the wild-type group A and group C
rotaviruses. (A) The individual rotavirus proteins in wild-type group C
bovine Shintoku and wild-type group A bovine IND rotavirus were
detected by antiserum against group C Shintoku rotavirus. The
Shintoku rotaviruses were concentrated 10 times more than IND rota-
viruses before loading onto acrylamide gels. M, molecular weight
markers (kilodaltons). Lane 1, group C bovine Shintoku rotavirus; Lane
2, group A bovine IND rotavirus. (B) The individual rotavirus proteins in
wild-type group A IND rotavirus and group C Shintoku rotavirus were
detected by antiserum against group A human Wa rotavirus. Lane 1,
group A IND rotavirus; Lane 2, group C Shintoku rotavirus. F, VP2; },
VP6; Š, VP7.
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immunoprecipitation (Estes et al., 1986; Jiang et al., 1990),
ELISA, or immunofluorescence (IF) tests (Bridger et al.,
1983; Estes et al., 1986; Snodgrass et al., 1984), cross-
reactivity between group A and group C rotaviruses was
reported by Tsunemitsu et al. (1992). They found that the
hyperimmune antisera raised against bovine Shintoku
and porcine Cowden group C rotaviruses in group A
rotavirus seronegative animals also reacted with bovine
NCDV group A rotavirus at 64- to 128-fold lower titers
than against group C rotavirus, and the hyperimmune
antisera against bovine NCDV group A rotaviruses in
group C rotavirus seronegative animals reacted with the
Shintoku and Cowden group C rotaviruses at 512-fold
lower titers than to group A rotaviruses. The discrepan-
cies between some of the previous papers and ours
could be explained by the different affinities of the poly-
clonal antibodies generated and the titers of the antisera
against the group C rotavirus used in the studies. How-
ever the cross-reactivity results noted with the polyclonal
antibodies were also evident with monoclonal antibody
to VP6 of group C rotavirus but not with monoclonal
antibodies to an unrelated coronavirus (Tsunemitsu et
al., 1992).
In our study, the group A RF VP2 also showed weak
cross-reactivity with hyperimmune antisera against
group C rotaviruses, but which was inconsistent depend-
ing on the length of the incubation time. The amino acid
identity of the VP2 protein among group A rotaviruses is
78–96%, whereas between group A RF BRV and group B
ADRV HRV, and between group A RF BRV and group C
porcine rotavirus, the identity is 20 and 46%, respectively.
The VP2 interacts with rotavirus dsRNA and the nucleic
acid-binding domain in VP2 was localized between
amino acids 1 to 132 (Labbe et al., 1991). Using group A
SA11 rotavirus temperature-sensitive mutants, it was
shown that mutation of alanine to asparagine at amino
acid 387 in VP2 interfered with assembly of VP2 and VP6
(Mansell et al., 1994). Although the interactions between
VP2 and VP6 are not well defined, it has been shown that
amino acids 251–397 of SA11 VP6 were responsible for
binding to SA11 VP2 (Clapp and Patton, 1991).
The domains in VP6 responsible for attachment of VP7
have not been previously reported. However, in our
study, coexpression of group A VP2 and VP6, and group
C VP7, or group A VP2 and VP7, and group C VP6 resulted
in hybrid 2/6/7 TLPs, indicating that the domains respon-
sible for interaction between VP6 and VP7 proteins are
also conserved between group A (IND) and group C
(Shintoku) BRV. Interestingly, in our study, the yields of
the group A/C hybrid 2/6/7 TLPs were lower than those
of homologous group A IND 2/6/7 TLPs (5- to 7-fold) or
hybrid 2/6 DLPs (8-fold), and the yields were similar
among hybrid VLPs with group A or group C VP6 pro-
teins. Some of the reasons for the lower yields of the
hybrid VLPs could be the inefficient assembly of the VP2,
VP6, and VP7 proteins of different rotavirus serogroups
or their instability after assembly. In future studies, it
would be interesting to investigate those conserved re-
gions of VP6 and VP7 proteins responsible for formation
of hybrid 2/6/7 TLPs between group A and C rotaviruses.
The ability to form group A/C hybrid 2/6/7 TLPs in vitro
suggests that there is a possibility that intergroup hybrid
reassortants between group A and group C rotaviruses
might occur in coinfected hosts in nature. However, it is
unknown if the interaction of VP6 and VP7 proteins of
group A and C rotaviruses readily occurs in the presence
of the homologous VP6 or VP7 proteins. To address this,
the mixed expression of A-VP6 and C-VP6 with A-VP2 to
assess hybrid group A/C DLP formation would provide
new additional information on the homologous and het-
erologous interactions between VP2 and VP6, which
would be interesting to try in future studies. Furthermore,
the reassortants with hybrid VP6 and VP7 proteins must
be stable enough to maintain their hybrid reassortant
populations and infect new hosts after being shed in
feces. In addition, the morphogenesis of rotaviruses is
complex and involves RNA-protein interactions. Because
the 5 and 3 ends of the dsRNA genomes of group A and
C rotaviruses are conserved within a group for the ho-
mologous dsRNA segments, it was speculated that the
ends of each genome are involved in protein interac-
tions, suggesting that conditions for hybrid reassortant
formation between group A and C rotaviruses may not be
favorable in vitro or in vivo.
In summary, coexpression of group A BRV RF VP2,
group A (IND) or C (Shintoku) VP6, and group C
(Shintoku) or A (IND or 2292B) VP7 resulted in formation
of group A/C hybrid TLPs. To our knowledge, this is the
first report that the rotavirus VP6 protein can support the




Rhesus monkey kidney (MA104) cells were grown and
maintained in minimal essential medium (MEM; Gibco
Life Technologies, Grand Island, NY) in a humid CO2
incubator at 37°C. The Sf9 cells were maintained in
complete TNM-FM medium (JRH, Rockville, MD) includ-
ing 10% fetal bovine serum (FBS) in the presence of 1%
pluronic acid solution (JRH, Rockville, MD). The Sf9 cells
were used for infection until they were passaged up to 30
times, and then they were replaced with new cells at a
low passage level. The group C BRV Shintoku strain and
the group A BRV IND (P[5]G6) and 2292B (P[11]G10)
strains were cultivated in MA104 cells in the presence of
trypsin and collected by freezing and thawing three times
as previously described (Chang et al., 1999). The dsRNA
of group B HRV ADRV strain was kindly provided by Dr.
Qian Yuan, Capital Institute of Pediatrics, Beijing, China.
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Gene clones
The clarified supernatants containing the rotaviruses
were collected and rotavirus dsRNAs were extracted
from the viral pellets as described previously (Rosen et
al., 1992). The viral genes included for group A rotavi-
ruses, the VP6 and VP7 genes of BRV IND (P[5]G6) strain,
and the VP7 gene of BRV 2292B (G10) strain; for group C
rotavirus, the VP6 and VP7 genes of BRV Shintoku strain;
for group B rotavirus, the VP6 gene of HRV ADRV strain.
Briefly, the rotavirus genes were RT-PCR-amplified in
an RT-PCR mixtures containing 10  buffer (200 mM
Tris-HCl, pH 8.3, 2.5 mMMgCl2, KCl, 0.05% gelatin), dNTP
(10 mM, each), 200 ng of each 5 and 3 end primers, 5
U RNAs in (Promega, Madison, WI), 10 U of reverse
transcriptase (Promega), and 2.5 U of Taq polymerase
(Promega). First-strand cDNA synthesis was accom-
plished by incubating the above mixture for 90 min at
42°C. Thirty amplification cycles were conducted, with
each cycle at 94°C for 1 min (denaturation), 48°C for 1
min (annealing), and 72°C for 2 min (extension). The
primers for RT-PCR were as follows: for VP6 gene of
group A rotavirus, 5-GGCTTTAAAACGAAGTCTTC-3
(sense, nucleotide 1–20 for Wa VP6 gene, GenBank Ac-
cession No. K02086) and 5-GGTCACATCCTCTCACTA-
CA-3 (antisense, 1337–1356 for Wa VP6); for VP7 gene of
group A rotaviruses, 5-GGCTTTAAAAGAGAGAATTTC-3
(sense, 1–21 for Wa VP7, K02033) and 5-GGGTCACATC-
GAACAATTCTA-3 (antisense, 1043–1062 for Wa VP7); for
VP6 gene of group C rotavirus Shintoku, 5-GCATTTA-
AAATCTCATTCAC-3 (sense, 1–20 for shintoku VP6,
M88768) and 5-AGCCACATAGTTCACATTTC-3 (anti-
sense, 1333–1352 for shintoku VP6); for VP7 gene of
shintoku, 5-GGCATTTAAAAAAGAAGGAGC-3 (sense,
1–21 for shintoku VP7, U31750) and 5-AGCCACATAAT-
CTCGTTTAC-3 (antisense, 1044–1063 for shintoku VP7);
and for VP6 gene of ADRV VP6 group B rotavirus, 5-
ggtttaaatagcccaaccgg-3 (sense, 1–20 for ADRV VP6,
M55982) and 5-GGGTTTTATTGCTTATTTTTCG-3 (anti-
sense, 1247–1269 for ADRV VP6). The full-length RT-PCR
products were analyzed on 1% agarose gels using stan-
dard procedures (Sambrook et al., 1989). The RT-PCR
products were cloned into the pCR2.1 or pCRBac vector
(Invitrogen, Carlsbad, CA).
Construction of baculovirus recombinants
The full-length clones were subcloned into pVL1392
(Pharmingen, San Diego, CA) or pBlueBac4.5 (Invitrogen)
baculovirus transfer vectors to construct the baculovirus
recombinants. The Bac-N-Blue linearized baculovirus
DNA (Invitrogen) was mixed with 0.5 g of the recombi-
nant transfer plasmids, 20 l of CellFectin reagent, and 1
ml of Grace’s insect medium (JRH). The mixtures were
incubated at room temperature for 15 min, added to Sf9
cells (2  106 cells), and plated on 60-mm plates, and
after 4 h of incubation, the mixtures were replaced with
the TNM-FH medium (10% FBS). Plaque-purified recom-
binant viruses were prepared from each of the transfec-
tions. The recombinant virus encoding the BRV RF VP2
was kindly provided by Dr. J. Cohen, Laboratoire de
Virologie et d’Immunologie Moleculaire, INRA, Jouy-en-
Josas Cedex, France.
Production of VLPs
To produce the triple-layered 2/6/7 VLPs, Sf9 cells
(3.0  107 cells per 162 cm2 flask) were coinfected with
different combinations of baculovirus recombinants at a
multiplicity of infection (m.o.i.) of 5 for each virus. The
combinations were A-VP2/A-VP6/C-VP7, A-VP2/C-VP6/C-
VP7, A-VP2/C-VP6/A-VP7(2292B), and A-VP2/C-VP6/A-
VP7(IND). The 2/6 DLPs were produced in an identical
way by coexpressing recombinant baculoviruses encod-
ing the VP2 or the VP6 genes. The combinations were
A-VP2/A-VP6, A-VP2/C-VP6, or A-VP2/ADRV VP6.
The infections were done in TNM-FM medium contain-
ing 2% FBS. The cells and medium were harvested at 6–8
days postinfection, and the medium was clarified by
centrifugation at 3000 g, at 4°C for 15 min. The collected
medium was layered over a 35% sucrose cushion and
centrifuged at 100,000 g, at 4°C for 1.5 h. The pellets
were collected and resuspended in TNC buffer (10 mM
Tris [pH 7.4], 140 mM NaCl, 10 mM CaCl2), and then CsCl
was added to obtain a refractive index of 1.3665 and the
CsCl gradients were centrifuged at 100,000 g, at 4°C for
18 h. The gradient fractions were collected, pooled by
density, desalted by centrifugation at 100,000 g, at 4°C
for 2 h, and suspended in TNC buffer to 1/200th of the
original volume.
Characterization of VLPs
IEM. The VLPs were incubated with guinea pig hyper-
immune antisera against either group A (Wa HRV, Chang
et al., 2000) or group C rotavirus (Shintoku BRV, Tun-
emitsu et al., 1992), overnight at 4°C. The mixtures were
centrifuged in TC buffer (0.1 M Tris [pH 7.4], 10 mM CaCl2)
at 100,000 g, at 4°C for 2 h. The pellets containing the
VLPs were suspended with 25 l of TC buffer and
stained with phosphotungstic acid (pH 7.0), followed by
examination using a Philips 201 electron microscope.
SDS-PAGE and Western blot analysis of the VLPs. The
double- and triple-layered VLPs were solubilized in
Laemmli buffer and separated on polyacrylamide gels
as previously described (Laemmli, 1970). Gels were
stained with Simply blue safestain (Invitrogen). For West-
ern blotting assay, the proteins separated by SDS-PAGE
were electroblotted onto the nitrocellulose membranes
in transfer buffer (25 mM Tris, 192 mM glycine, 20%
methanol). The membranes were blocked with 2% nonfat
dry milk in phosphate-buffered saline containing 0.05%
Tween (TPBS) for 30 min at room temperature, washed 3
times with TPBS, and incubated for 2 h at room temper-
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ature with the guinea pig antisera prepared against
group A Wa HRV (1:300), group C Shintoku BRV (1:100), or
preimmune serum (1:100) diluted in TPBS. After washing
three times with TPBS, rabbit horseradish peroxidase-
conjugated anti-guinea pig immunoglobulin G (KPL,
Gaithersburg, MD) was added and incubated for 2 h at
room temperature. The blots were washed again and
developed with tetramethylbenzidine (TMB; KPL, Gaith-
ersburg, MD).
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